Inuvo is trading 6.77% up at $0.83 after rebounding from the August 14, 2026 close of $0.78, when shares fell 9.08%; no new August 17 company-specific announcement clearly explains the rebound.
- The previously announced CFO transition became effective August 17, after being disclosed August 11.
- Recent Q2 results showed substantially lower revenue, limiting confidence in a fundamental catalyst.